Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Entrustable Professional Activities - Top-Institutions - MDSpire

Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Entrustable Professional Activities

This study elucidates clinical responsibilities of current US radiation oncology APPs in order to inform educational needs.

  • By

  • Brett S. Wagner

  • Levi Martinka

  • Drew Gordon

  • Sarah Anderson

  • Katherine Bukolt

  • Kate Martin

  • Daniel W. Golden

  • March 4, 2026

  • 16 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Rush University Medical Center
    Rush University Medical Center

    Chicago, Illinois

    Key Differentiators

    • Radiation Oncology

  • #2

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Radiation Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Radiation Oncology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Radiation Oncology

  • #5

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Radiation Oncology

Original Source(s)

Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Entrustable Professional Activities

  • by Brett S. Wagner, Levi Martinka, Drew Gordon, Sarah Anderson, Katherine Bukolt, Kate Martin, Daniel W. Golden

  • March 4, 2026

Related Content

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer